Citations

Clear

7544 citation(s) found for "Ku, Matthew".

Artificial Intelligence Applications Versus Manual Methods For Literature Retrieval: A Comparative Analysis
O’Rourke, Jenny , Byrne, Matthew, Schroers, Ginger , O’Rourke, Jenny , Byrne, Matthew David

Mayo Clinic

Western Journal of Nursing Research | June 10, 2026 | Volume: 48 | Issue: 8 | Pages: 887-894

10.1177/01939459261451723 | PMID 42267644 Get It

Background: Artificial intelligence (AI), particularly generative and large language models, is being used in nursing education, practice, and scholarly writing. Generative AI applications have been specifically examined for their use in conducting literature reviews with evidence supporting reduced production time of scholarly work. However, there has been limited investigation of their levels of accuracy with identifying references for a literature review. Objective: The purpose of this study was to compare human-generated citations of literature reviews with AI literature-review generated citations. Methods: Using a comparative exploratory design, references from 4 human-written literature reviews, 2 published and 2 unpublished, on 4 different topics, were compared to references derived from 2 AI literature applications, Consensus and Elicit. Three prompting strategies were utilized, including prompts generated using ChatGPT-4. Agreement between the AI and human references was evaluated. Results: The percent of agreement between AI and human generated reference lists ranged from 0% to 63.6%. The Consensus application had a greater overall mean rate of match (21.3%) as compared to Elicit (3.7%). The use of a ChatGPT-4 prompt did not significantly impact results, and there were no differences based on published or unpublished literature reviews. Conclusion: The 2 literature-based applications examined in this study offered a glimpse of their potential use and limitations. The use of an AI literature review application may support but not replace human work.
Industry payments by drug and medical device manufacturers to Sexual Medicine Society of North America fellowship program directors
Kim, Tae-Hee , Gross, M, Köhler, Tobias , Ziegelmann, M, Gross, Martin , Ziegelmann, Matthew J, Helo, Sevann , Kim, Tae-Hee , Ziegelmann, Matthew

Mayo Clinic

The Journal of Sexual Medicine | June 9, 2026 | Volume: 23 | Issue: 7 | Pages: No page available

10.1093/jsxmed/qdag196 | PMID 42348864 Get It

Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Fathima, Saubia, Wong, Margaret Mei‐Kay, Gonzalez-Lugo, Jesus, Geyer, Susan M. , Alsugair, Ali, Langer, Kimberly J., Lasho, Terra L. , Finke, Christy, Choi, Jun, Abdul‐Hay, Maher, Ho, Gary , Litzow, M. R., Matin, Aasiya , Hefazi, M., Shah, Mithun V., Al-Kali, Aref, Begna, Kebede H. , Gangat, Naseema , Saliba, A., Kewan, Tariq, Bartoo, Gabriel, Kutzke, Jade, McCullough, Kristen, Sullivan, Megan, Reichard, Kaaren K., Olteanu, Horatiu , Kusne, Yael , Palmer, Jeanne, Punwani, Nathan , Riwes, Mary, Krakow, Elizabeth F., Langston, Amelia , Kourelis, Taxiarchis, Foran, James M. , Patnaik, Mrinal M., Beck, David B. , Mangaonkar, Abhishek A. , Krakow, Elizabeth F. , Riwes, Mary , Alsugair, Ali , Lasho, Terra L , Ho, Gary , Durani, Urshila , Hogan, William J , Gangat, Naseema , Saliba, Antoine N , Go, Ronald S , Warrington, Kenneth J , Olteanu, Horatiu , Murthy, Hemant S , Badar, Talha , Kusne, Yael N , Chhabra, Saurabh , Langston, Amelia , Foran, James M , Koster, Matthew J , Beck, David B , Alkhateeb, Hassan B , Fathima, Saubia , Gonzalez‐Lugo, Jesus D. , Geyer, Susan , Sirenko, Maria , Finke, Christy M. , Abdul‐Hay, Maher , Litzow, Mark R. , Durani, Urshila , Hefazi, Mehrdad , Hogan, William J. , Shah, Mithun V., Al‐Kali, Aref , Saliba, Antoine N. , Go, Ronald S. , Bartoo, Gabriel , Kutzke, Jade L. , McCullough, Kristen , Warrington, Kenneth J. , Sullivan, Megan M. , Reichard, Kaaren K. , Murthy, Hemant S. , Badar, Talha , Palmer, Jeanne , Chhabra, Saurabh , McGuirk, Joseph P. , Kourelis, Taxiarchis , Dingli, David , Koster, Matthew J. , Patnaik, Mrinal M. , Alkhateeb, Hassan B. , Mangaonkar, Abhishek A.

Mayo Clinic

American Journal of Hematology | June 9, 2026 | Volume: 101 | Issue: 9 | Pages: 2166-2176

10.1002/ajh.70401 | PMID 42260942 Get It

ABSTRACT Hypomethylating agents (HMA) and allogeneic hematopoietic stem cell transplantation (alloHSCT) have both demonstrated remissions in VEXAS; however, comparative data is lacking. We conducted a multicenter, retrospective analysis of 66 patients diagnosed with VEXAS syndrome treated with HMA ( n = 35) or alloHSCT ( n = 31). Baseline characteristics such as genetics, co‐morbidities, and performance status were balanced between the groups, except older age in the HMA group. Median follow‐up from therapy initiation was 18 months (95% CI: 11–26), and 14 (21%) deaths were reported (alloHSCT n = 3; HMA n = 11). Among all evaluable patients within the alloHSCT cohort, all patients achieved molecular remission, and a substantial proportion of patients discontinued glucocorticoids (58%). In contrast, HMA therapy was associated with lower but meaningful rates of molecular remission (22%) and glucocorticoid discontinuation (6%). In a real‐world setting, HMA therapy was associated with a high discontinuation rate related to toxicity or lack of response. On multivariable analysis adjusted for age and Charlson Comorbidity Index, alloHSCT was associated with improved overall survival (HR = 0.20, 95% CI: 0.05–0.81; p = 0.024). This association remained consistent across multiple ancillary sensitivity analyses, including restriction to transplant‐eligible patients, patients aged ≤ 75 years, 1:1 matching, and propensity score‐based weighted analyses. Although limited by retrospective design, these findings suggest that alloHSCT remains an attractive and potentially curative strategy in selected patients with VEXAS. Prospective validation of these findings is warranted.
Size-dependent alterations in phrenic motor neuron perineuronal nets following cervical spinal hemisection
Cheung, Sang Won , Fogarty, Matthew J. , Zhan, Wen-Zhi, Bellingham, Mark C. , Noakes, Peter G. , Sieck, Gary C. , Bellingham, Mark C , Sieck, Gary , Fogarty, Matthew J , Zhan, Wen‐Zhi

Mayo Clinic

Journal of Neurophysiology | June 8, 2026 | Volume: 136 | Issue: 1 | Pages: 180-190

10.1152/jn.00033.2026 | PMID 42258373 Get It

Neuroplastic changes in phrenic motor neurons that underlie recovery from spinal cord injury may be mediated by perineuronal nets. We show that changes in perineuronal nets around phrenic motor neurons occur within 7 days after cervical spinal cord injury, and that the increase in perineuronal nets around larger phrenic motor neurons was more pronounced. These changes are consistent with substantial reorganization of the neural network onto intact phrenic motor neurons following cervical spinal cord injury.
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection Criteria
Li, Eric V. , Ahmed, Eman E., Ahmed, Mohamed E., Wang, Michael K., Diaz‐Cobo, Julian, O'Byrne, Jamie, Cheville, John C., Shah, Paras H., Frank, Igor, Tollefson, Matthew K., Boorjian, S., Sharma, Vidit, Khanna, Abhinav, Karnes, R Jeffrey, Ahmed, Mohamed E., Diaz-Cobo, Julian, Cheville, John C. , Frank, Igor, Tollefson, Matthew K. , Sharma, Vidit , Karnes, R. Jeffrey

Mayo Clinic

The Prostate | June 8, 2026 | Volume: 86 | Issue: 12 | Pages: 1251-1257

10.1002/pros.70206 | PMID 42257571 Get It

ABSTRACT Background While guidelines state that patients with NCCN favorable intermediate risk (FIR) prostate cancer (PCa) may consider active surveillance (AS), there is a relative lack of longer term follow up data informing AS inclusion criteria of patients with Grade Group (GG) 2 prostate cancer in the MRI era. Here we evaluate patient outcomes from a MRI‐screened AS‐eligible cohort of FIR GG2 PCa receiving radical prostatectomy (RP). Methods Patients with prostate MRI, NCCN FIR GG2 PCa (PSA < 10 ng/mL, ≤ cT2a, < 50% core positivity), and no prior treatments who underwent RP from 2015 to 2023 were included from a prospectively maintained prostatectomy registry. Primary outcomes were adverse pathologic features (APF) at RP (GG3‐5, ≥ pT3a, or pN1) and biochemical recurrence (BCR). Logistic regression and Cox regression identified factors associated with APF at RP and time to BCR, respectively. Results Of 522 patients, 110 (21%) had APF at RP and 45 (9%) developed BCR with median follow up 2.4 years (IQR 1.3–2.8). On multivariable logistic regression, % Gleason pattern 4 (%GP4, %GP4 > 25% OR 2.14, 95% CI 1.28–3.58, p = 0.004) was independently associated with APF. On multivariable Cox regression for time to BCR, PSAD (HR 1.06, 95% CI 1.04–1.09, p < 0.001) and positive surgical margins (HR 1.06, 95% CI 1.09–3.78, p = 0.03) were independently associated with BCR. PIRADS, % core positivity, and specimen involvement were associated with neither APF nor BCR. Conclusions % Gleason pattern 4 > 25% and PSAD are the primary factors associated with adverse outcomes and should be considered for patients with FIR GG2 PCa considering active surveillance. PIRADS and measures of biopsy cancer volume were not associated with APF or BCR. These results may inform patient selection for active surveillance among patients with FIR GG2 PCa.
Associations Between Cumulative Head Trauma and Self‐Reported Parkinsonism and Parkinson's Disease in Former Soccer Players
Miner, Annalise E., Kmiecik, Matthew J., Dunckley, Nathaniel, Adler, Charles H., Driver‐Dunckley, Erika , Nowinski, Christopher J. , Gottesman, Joshua , Tripodis, Yorghos, Stern, Robert A., McKee, Ann C., Stein, Thor D., Alosco, Michael L., Driver-Dunckley, Erika D., Miner, Annalise E., Kmiecik, Matthew J. , Namburi, Niharika , Dunckley, Nathaniel, Adler, Charles H. , Tripodis, Yorghos , McKee, Ann C. , Stein, Thor D. , Mez, Jesse , Briggs, Farren , Alosco, Michael L.

Mayo Clinic

Movement Disorders | June 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/mds.70380 | PMID 42252813 Get It

Abstract Background Cumulative head trauma, encompassing repetitive head impacts (RHI) and traumatic brain injury (TBI), has been associated with later‐life neurodegenerative disease. Studies on parkinsonism/Parkinson's disease (PD) have evaluated RHI and TBI in isolation, yielding mixed results. Cumulative head trauma may better predict PD risk. Objective To examine independent and cumulative effects of RHI through soccer participation and TBI history on PD diagnosis and age at diagnosis. Methods We used a cross‐sectional cohort design with data from the Fox Insight study. Participants completed self‐report questionnaires on PD diagnosis, TBI (no TBI, TBI with loss of consciousness [LOC], TBI without LOC), and sport participation. Multivariable logistic regressions examined the effects of soccer, TBI group, and their interaction on PD diagnosis. Cox proportional hazards examined associations with time to PD diagnosis. Covariates included age, sex, race, education, income, body mass index, heart disease/diabetes, and family PD history. Results Among 1231 participants (mean[SD] age = 66.12[10.60]), 278 played soccer (953 non–contact and collision sport [CCS] athletes). Participants reported no TBI (390[33%]), TBI without LOC (495[43%]), or TBI with LOC (258[23%]). Overall, 768(62%) reported a PD diagnosis (mean[SD] age at diagnosis = 59.02[9.86]). A significant soccer × TBI interaction indicated that soccer players with TBI with LOC had 2.6× higher odds of PD compared to non‐CCS athletes without TBI (OR [95% CI] = 2.600[1.085–6.305], P = 0.033). Former soccer players with TBI with LOC had a 15.6% higher hazard of early PD diagnosis (HR = 1.469, P = 0.027) compared to non‐CCS athletes with no TBI. Conclusion Cumulative head trauma (RHI + TBI) increased PD risk and lowered age at onset. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
The evidence for old age motor neuron death: A scoping review
Cheung, Sang Won , Fogarty, Matthew J. , Fogarty, Matthew J

Mayo Clinic

Physiological Reports | June 6, 2026 | Volume: 14 | Issue: 11 | Pages: No page available

10.14814/phy2.70967 | PMID 42249658 Get It

Abstract Age‐related neuromuscular dysfunction is widely recognized; however, the extent to which aging is accompanied by motor neuron (MN) loss remains underexplored. This review evaluates evidence for MN loss with aging across species and anatomical motor pools. We synthesize PUBMED studies in humans, non‐human primates, rats and mice within the spinal cord and brainstem. Attention was given to the methodological approach used to quantify MNs and categorized based on what MNs were quantified (specific pools, vertebral levels, lateral motor columns). Methods were assessed qualitatively, based on stereological and non‐stereological density counting approaches, and the staining techniques identified as optimal or suboptimal by defined criteria. To facilitate cross‐study comparison we conducted quantitative assessments including: coefficients of variance, percentage differences between groups and standardized effect sizes calculated with Cohen's d . Across species and anatomical regions, the overall literature supports the presence of age‐related MN loss. Evidence is strongest in studies using robust counting approaches such as stereology, and appropriate MN markers. As age‐related MN degeneration is more heavily investigated and becomes a locus of intervention, future work must employ rigorous methodological standards to accurately determine the extent, regional specificity, and functional consequence of aging MN loss.